Effects of Proteasome Inhibitor MG132 on number and Activity of Endothelial Progenitor cells from Peripheral Blood

Chang-qing DU,Xiao-sheng HU,Xue-yan YAO

DOI: https://doi.org/10.3969/j.issn.1009-816X.2009.02.007

2009-01-01

Abstract:Objective To investigate the effects of low-dose proteasome inhibitor MG132 on the number and function of peripheral blood endothelial progenitor cells(EPCs).Methods Mononuclear cells(MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation,and then the MNCs were plated on fibronectin-coated culture dishes.After 7days culture,adherent cells were treated with low-dose proteasome inhibitor MG132 in a series of final concentrations of 20nmol/l,50nmol/l,100 nmol/l,200nmol/l for 12,24,48h.EPCs were identified as adherent cells double positive for DiLDL-up-take and lectin binding by direct fluorescent staining under a laser scanning confocal microscope.EPCs proliferation,adhesion and migration were assayed with MTT,adhesion assay and modified Boyden chamber assay,respectively.Results Incubation of isolated human MNCs with low-dose proteasome inhibitor MG132 decreased the number of EPCs,and MG132 also decreased EPCs proliferative,adhesive and migration capacity in a concentration-and time-dependent manner.Conclusions Low-dose proteasome inhibitor MG132 was found to decrease the numbert,proliferation,adhesive and migratory capacities of the EPCs.